Shandong Buchang Pharmaceuticals Co., Ltd. Class ASSE: 603858

Announcement on Progress in Proposed Transfer of Equity in a Holding Subsidiary and Waiver of the Right of First Refusal

· Issued by Shandong Buchang Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Progress in Proposed Transfer of Equity in a Holding Subsidiary and Waiver of the Right of First Refusal

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis